Mucosal-cell counts in ulcerative and granulomatous colitis.

Area of Science:

• Gastroenterology
• Histopathology
• Inflammatory Bowel Disease (IBD) research

Background:

• Inflammatory bowel disease (IBD) diagnosis relies on clinical, endoscopic, and histological findings.
• Differentiating ulcerative colitis (UC) and Crohn's disease (granulomatous colitis) can be challenging, particularly when endoscopic signs normalize.
• Histological analysis of rectal mucosal biopsies offers objective cellular data for diagnosis and monitoring.

Purpose of the Study:

• To evaluate the diagnostic value of epithelial and connective-tissue cell counts in rectal biopsies for differentiating ulcerative colitis and granulomatous colitis.
• To assess how these cell counts change during disease activity, healing, and in response to therapy.
• To determine if cell counts can aid in differential diagnosis when endoscopic findings are normal.

Main Methods:

• Rectal mucosal biopsies were obtained from 215 patients with ulcerative colitis, 98 with granulomatous colitis, and 50 controls.
• Quantitative analysis of epithelial cells (including mucous goblet cells) and connective-tissue cells (macrophages, plasma cells) was performed.
• Statistical analysis was employed to compare cell counts between disease groups and controls, and across different disease states and treatments.

Main Results:

• Significantly decreased mucous goblet cells were observed in both active ulcerative colitis and granulomatous colitis, with an increase during healing.
• Active ulcerative colitis showed higher numbers of pyknotic and karyorrhectic epithelial cells compared to granulomatous colitis.
• Inactive ulcerative colitis retained signs of inflammation, while healed granulomatous colitis exhibited increased lamina propria macrophages.
• Cell counts proved valuable for differential diagnosis once sigmoidoscopic appearance normalized.
• Therapy with prednisone or 6-mercaptopurine reduced acute inflammation (neutrophils) in ulcerative colitis.
• Salicylazosulfapyridine, prednisone, or 6-mercaptopurine decreased chronic inflammation (plasma cells); 6-mercaptopurine with another agent most increased macrophages (healing indicators).

Conclusions:

• Quantitative histological analysis of rectal biopsies provides valuable differential diagnostic information for ulcerative colitis and granulomatous colitis, especially in resolving or quiescent disease.
• Specific cellular changes, such as mucous goblet cell depletion and macrophage infiltration, correlate with disease activity, healing, and therapeutic response.
• Cellular profiling in rectal biopsies can objectively complement endoscopic and clinical assessments in managing inflammatory bowel disease.